Companies · Other Health Care

Yumanity Holdings, LLC

BOSTON · Other Health Care

Diligence memoA one-page analyst read on Yumanity Holdings, LLC — recommendation, valuation, rhythm, risks.
$103.8M
Total raised · real
3
Rounds
0.7×
Latest step-up
Top 5%
Sector rank · raised
Series C
Latest stage · inferred · Fri Jun 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Yumanity Holdings, LLC looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.43× the median modeled value of Series C Other Health Care companies in 2019–2021 (46 peers) — value vs value, same stage and era.
Dormant
  • Last raise 6.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Yumanity Holdings, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
10.4 yr record
Peak capital year was 2016 with $51.0M across 1 filings.
Market position
ahead of 96% of Other Health Care peers
Capital scale is ahead of 96% of Other Health Care peers; modeled value is above 93% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2016: $51.0M across 1 filings.
  • Largest single filing was $51.0M on 2016-02-08.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Yumanity Holdings, LLC is one of 5377 Other Health Care companies tracked from BOSTON. By capital raised it ranks among the largest (ahead of 96% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
11
Investors (latest)
2015
Year incorporated
2020-06-19
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeries C · 2016-02-08 Raised $51M (real) Modeled valuation $1.2B (est)$51M$1.2BSeries C2016Series C · 2018-06-19 Raised $31M (real) Modeled valuation $711M (est)$31M$711MSeries C2018Series C · 2020-06-19 Raised $22M (real) Modeled valuation $494M (est)$22M$494MSeries C2020+$31M+$22MCumulative $104M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series C$51.0M · 2016
Series C extension$31.1M · 2018
Series C extension$21.6M · 2020

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 20%.

Modeled valuation trajectory
$494.4M
Base estimate est.
$78.6M
Conservative case
$1.3B
Upside case
$144.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series C · modeled $1.2B · 2016-02-082016Series C · modeled $711.5M · 2018-06-19Series C · modeled $494.4M · 2020-06-192020
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
6.0 yr
Elapsed time used
6.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
26 mo
Avg between rounds
$23.8M/yr
Capital velocity
10.4 yr
On record since
2016
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 43× above median
This company$103.8M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.5× of median
This company$21.6M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 22× above median
This company$494.4M
Sector median$22.1M

Raised more than 96% of sector peers (real $). Modeled value above 93% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #43 of 46.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Avail Medsystems, Inc. · Series C Raised $126.7M · modeled $2.2B (est)Whoop, Inc. · Series C Raised $180.4M · modeled $2.1B (est)HRGi Holdings, Inc. · Series C Raised $91.2M · modeled $2.1B (est)Ambulnz, Inc. · Series C Raised $90.0M · modeled $2.1B (est)MedAvail, Inc. · Series C Raised $97.0M · modeled $2.0B (est)SOC Telemed, Inc. · Series C Raised $103.0M · modeled $1.9B (est)Eargo, Inc. · Series C Raised $187.4M · modeled $1.9B (est)Truth Holdings, L.P. · Series C Raised $88.8M · modeled $1.6B (est)NeuroPace Inc · Series C Raised $208.6M · modeled $1.5B (est)DermTech, Inc. · Series C Raised $98.9M · modeled $1.5B (est)Mydna, Inc · Series C Raised $72.1M · modeled $1.4B (est)Ancora Heart, Inc. · Series C Raised $151.3M · modeled $1.4B (est)Yumanity Holdings, LLC (this company) Raised $103.8M · modeled $494.4M (est)Yumanity Holdings, LLC
CompanyStageRaised · realValue · estvs peer med.
Avail Medsystems, Inc.Series C$126.7M$2.2B1.87×
Whoop, Inc.Series C$180.4M$2.1B1.81×
HRGi Holdings, Inc.Series C$91.2M$2.1B1.81×
Ambulnz, Inc.Series C$90.0M$2.1B1.79×
MedAvail, Inc.Series C$97.0M$2.0B1.75×
SOC Telemed, Inc.Series C$103.0M$1.9B1.65×
Eargo, Inc.Series C$187.4M$1.9B1.61×
Truth Holdings, L.P.Series C$88.8M$1.6B1.43×
NeuroPace IncSeries C$208.6M$1.5B1.33×
DermTech, Inc.Series C$98.9M$1.5B1.29×
Mydna, IncSeries C$72.1M$1.4B1.26×
Ancora Heart, Inc.Series C$151.3M$1.4B1.24×
Yumanity Holdings, LLC this companySeries C$103.8M$494.4M0.43×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series C$51.0M2016-02-08$340.1M$1.2B85%
Series C$31.1M2018-06-19$207.5M$711.5M90%
Series C$21.6M2020-06-19$144.2M$494.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series C$51.0M2016-02-08
    • First recorded raise — entered as Series C.
    • 16 investors on this round.
  2. Series C$31.1M2018-06-19
    • Raised again after 28 mo — slower than the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 12 investors on this round.
  3. Series C$21.6M2020-06-19
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 11 investors on this round.
Intelligence
2022 ~Q3
Modeled next raise · ~26mo cadence
$21.6M
Modeled next size est.range $21.6M$34.6M
0.7×
Last step-up
$23.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
N. Anthony Coles2 other2016-02
RICHARD PETERS2 other2020-06
Cecil Anthony Pickett2018-06
Jeff Anthony Kelly2020-06
Jeffery Anthony Kelly2016-02
Joel Anthony Marcus2016-02
John Anthony Cox2016-02
Lynne Anthony Zydowsky2020-06
Patricia Anthony Allen2020-06
Paulash Anthony Mohsen2016-02
Rich Anthony Heyman2020-06
Richard Anthony Heyman2018-06
Registry & provenance

Yumanity Holdings, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1667560
SEC CIK
2015
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Kineta, Inc./DeBiotechnologySeries C$141.6M$34.3Mnetwork2 shared operators · same stage
InfoBionic, Inc.Other Health CareSeries C$103.8M$573.7Msame sector · same stage
Avive Solutions, Inc.Other Health CareSeries C$100.2M$515.7Msame sector · same stage
Mainstay Healthcare Properties, LPOther Health CareSeries C$100.0M$488.8Msame sector · same stage
Paradromics, Inc.Other Health CareSeries C$96.9M$570.0Msame sector · same stage
Procyrion, Inc.Other Health CareSeries C$112.0M$543.3Msame sector · same stage
Pill Club Holdings, Inc.Other Health CareSeries C$113.8M$757.8Msame sector · same stage
InspireMD, Inc.Other Health CareSeries C$117.2M$248.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Yuvo, Inc.Other Health CareSeries A$34.0M85%
Amity Holdings, LLCOther Health CareSeed$1.2M85%
Plethy Capital, LLCOther Health CarePre-Seed$1.5M83%
Wellclarity IncOther Health CareSeed$40.1M83%
FGC CorrMed Holdings, LLCOther Health CareSeries A$44.8M83%
KSMS Holdings, LLCOther Health CareSeries B$885.1M83%
MCH Ventures, Inc.Other Health CareSeed$7.1M82%
Peachy Corp.Other Health CareSeries B$309.9M82%
Frequently asked
How much funding has Yumanity Holdings, LLC raised?
Yumanity Holdings, LLC has raised approximately $103.8M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Yumanity Holdings, LLC's estimated valuation?
Provath's modeled valuation for Yumanity Holdings, LLC is approximately $494.4M (modeled range $78.6M–$1.3B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Yumanity Holdings, LLC at?
Yumanity Holdings, LLC's latest modeled financing stage is Series C. Its most recent recorded round closed around Fri Jun 19.
What does Yumanity Holdings, LLC do and where is it based?
Yumanity Holdings, LLC operates in the Other Health Care sector, based in BOSTON.
Explore related

See where Yumanity Holdings, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Yumanity Holdings, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.